The Global Impingement Syndrome Market Growth is Accelerated by Increased Adoption of Novel Diagnostic Methods


Impingement syndrome refers to a painful condition affecting the shoulders that occurs when soft tissues get compressed or pinched within the subacromial space. It is primarily caused due to repetitive overhead activities or because of instability or laxity of the shoulder joint. The global impingement syndrome market is witnessing strong demand owing to rising incidence rates of shoulder injuries associated with sports and extreme physical activities. Non-invasive diagnostic techniques such as magnetic resonance imaging (MRI) scans and ultrasound examinations play a crucial role in accurately identifying underlying anatomical abnormalities. The global impingement syndrome market is estimated to be valued at US$ 2,173.5 Mn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The growing adoption of advanced diagnostic methods such as MRI for precise evaluation of soft tissue lesions is a key growth driver for the global impingement syndrome market. MRI scans allow physicians to clearly visualize structures like rotator cuff tendons, biceps tendon, labrum and cartilage in three dimensions without using ionizing radiation. This has significantly enhanced diagnostic accuracy and aided in developing targeted treatment plans. Moreover, ongoing research efforts to develop novel biomarkers and imaging techniques for early diagnosis of impingement syndrome are expected to further fuel market expansion over the coming years.

Segment Analysis
Impingement syndrome market is dominated by non-surgical treatment segment. This is because non-surgical treatments such as medication and physical therapy are usually the first line of treatment recommended as they are safer options and can effectively relieve pain and improve shoulder function in many cases. Non-surgical treatments avoid risks associated with surgery and help rehabilitate the shoulder without any incisions.

Key Takeaways

The global impingement syndrome market is expected to witness high growth over the forecast period of 2023 to 2030. Factors such as rising prevalence of shoulder pain disorders, growing geriatric population, increasing incidence of sports injuries and automobile accidents are expected to drive the demand for diagnosis and treatment of impingement syndrome.

Regional analysis: North America is currently the dominant region in the impingement syndrome market. This is attributed to increasing healthcare expenditure, rising awareness about shoulder disorders, growing number of sports injuries and favorable reimbursement policies in the region. Asia Pacific is expected to witness fastest growth over the coming years. Improving access to healthcare facilities, rising disposable incomes, growing senior population in countries such as China and India are propelling the market growth in Asia Pacific.

Key players: Key players operating in the impingement syndrome market are Thermo Fisher Scientific Inc., GE Healthcare, Merck KGaA, Bio-Rad Laboratories, Inc., Lonza, Abcam plc, PerkinElmer Inc., Bio-Techne, BioVision Inc., Cell Signaling Technology, Inc., and Geno Technology Inc. Thermo Fisher Scientific and GE Healthcare have a significant market share due to their broad product portfolio and widespread distribution channels. Other players are focusing on new product launches, expanding to emerging markets and acquiring smaller companies to strengthen their positions in the impingement syndrome market.

Get more insights on this topic:

Third Generation Sequencing Market

Assistive Technology Market

Macrophage Marker Market

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more